. 2019 Jul 25;20(8):36–46. doi: 10.1002/acm2.12676

Table 7.

NTCP of heart, lung, and skin in nominal PB‐PB, PB‐MC, and MC‐MC plans of breast cancer.

Patient #	Heart			Skin			Ipsilateral Lung
	NTCP (%)			NTCP (%)			NTCP (%)
	PB‐PB	PB‐MC	MC‐MC	PB‐PB	PB‐MC	MC‐MC	PB‐PB	PB‐MC	MC‐MC
1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	1.0
2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.8
3	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.9	0.9
4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.6
5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.5
6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.9	1.8
7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.9
8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.8
9	0.0	0.0	0.0	0.2	0.1	0.1	0.9	1.0	0.8
10	0.0	0.0	0.0	0.1	0.1	0.1	1.5	1.6	1.6
Average	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	1.0
SD	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.4
P‐value		0.968^a	0.968^b		0.674^a	0.936^b		0.384^a	0.674^b

PB‐PB, PB optimization followed by PB dose calculation; PB‐MC, PB optimization followed by MC dose calculation; MC‐MC, MC optimization followed by MC dose calculation; NTCP, normal tissue complication probability.

P‐value for PB‐MC vs. PB‐PB.

P‐value for MC‐MC vs. PB‐PB.